Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 592-595, February 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saarinen, U. M.
Right arrow Articles by Siimes, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saarinen, U. M.
Right arrow Articles by Siimes, M. A.

Tumor Necrosis Factor in Children with Malignancies

Ulla M. Saarinen1, Eeva-Kaarina Koskelo, Anna-Maija Teppo and Martti A. Siimes

Children's Hospital [U. M. S., E-K. K., M. A. S.] and the IV Department of Medicine [A-M. T.], University of Helsinki, 00290 Helsinki, Finland

We measured serum tumor necrosis factor {alpha} (TNF) concentrations by a double-antibody radioimmunoassay method, with a detection level of 10 ng/liter, in 32 children with malignancies. Seventeen had acute lymphoblastic leukemia, 4 had acute nonlymphocytic leukemia, and 11 had solid tumors. At the diagnosis of malignant disease, 30 of the 32 patients had elevated serum TNF levels ranging up to 450 ng/liter. After complete remission status was achieved, 2–6 months from the diagnosis, the TNF levels were within the range of 130 healthy children who served as the reference group. Most of them had TNF levels below the detection limit. We consider the upper limit of normal to be 40 ng/liter. We conclude that elevated serum TNF concentration may be of potential significance in the diagnosis and follow-up of children with malignant diseases.

1 To whom requests for reprints should be addressed at the Children's Hospital, University of Helsinki, Stenbäckinkatu 11, 00290 Helsinki, Finland.

Received 7/25/89. Revised 10/16/89. Accepted 10/25/89.




This article has been cited by other articles:


Home page
Nutr Clin PractHome page
E. J. Ladas, N. Sacks, L. Meacham, D. Henry, L. Enriquez, G. Lowry, R. Hawkes, G. Dadd, and P. Rogers
A Multidisciplinary Review of Nutrition Considerations in the Pediatric Oncology Population: A Perspective From Children's Oncology Group
Nutr Clin Pract, August 1, 2005; 20(4): 377 - 393.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Bossola, M. Muscaritoli, P. Costelli, R. Bellantone, F. Pacelli, S. Busquets, J. Argiles, F. J. Lopez-Soriano, I. M. Civello, F. M. Baccino, et al.
Increased muscle ubiquitin mRNA levels in gastric cancer patients
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1518 - R1523.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Y. Liu, C. Fan, N. E. Olashaw, X. Wang, and K. S. Zuckerman
Tumor Necrosis Factor-alpha -induced Proliferation of Human Mo7e Leukemic Cells Occurs via Activation of Nuclear Factor kappa B Transcription Factor
J. Biol. Chem., May 14, 1999; 274(20): 13877 - 13885.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.